[1] |
LI Size, HUANG Qi, WU Xiaojie, WANG Shaonan, GUAN Yihui, XIE Fang, ZHANG Jing.
The application of positron emission tomography in the research and development of central nervous system drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(3): 316-327.
|
[2] |
ZHA Xian, SUN Luning, CHEN Chao, WANG Yongqing.
Pharmacokinetics, pharmacodynamics of esomeprazole in critically ill patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(10): 1152-1160.
|
[3] |
ZHANG Yuanmao, ZHANG Ran, LIAO Ruiwei, TAO Lin, MENG Xiuxiu, XU Chen, GAO Fangfang, A Jiye, WANG Guangji.
Pharmacokinetics and tissue distribution of tetrahydropalmatine, nobiletin, and costunolide in rats after oral administration of Dalitong extract
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(1): 37-51.
|
[4] |
WU Yujie, ZHAO Chengcheng, XI Qing.
Evaluation of tegacycline regimens in treatment of gram-negative bacterial infections with Monte Carlo simulation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(9): 1027-1033.
|
[5] |
LI Kun, LI Lulu, LI Nannan, HU Weihong, ZHOU Jianchao.
Effects of glycaemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 767-774.
|
[6] |
HE Xueru, LI Ying, MA Yinling, FU Yuhao, XUN Xuejiao, DONG Zhanjun.
Pharmacokinetic interaction study between sorafenib and dapagliflozin in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 498-507.
|
[7] |
HUANG Zhiwei, LI Yi, XU Xiaoyong, ZHANG Lei, SHEN Yifeng, LI Huafang.
Comparison of calculation results of five population pharmacokinetic analysis tools
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 525-535.
|
[8] |
LIU Xiumei, GUO Qianqian, FANG Yuan, CHEN Nan, QI Qi.
Pharmaceutical care of patients with antithrombotic therapy after transjugular intrahepatic portal shunt
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 556-560.
|
[9] |
LI Mengxue, HE Jie, YU Xiaxia, HU Linlin, SHAO Hua.
Research progress in population pharmacokinetics of rituximab
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(4): 468-474.
|
[10] |
YAN Qiangyong, XIANG Daxiong, ZHU Ronghua, YANG Lingfeng, YANG Xiding, LI Jingjing, FAN Xiao, LIU Sai, XIONG Shoujun, FANG Pingfei.
Bioequivalence study of cinacalcet hydrochloride tablets in healthy Chinese volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 171-177.
|
[11] |
XIAO Lei, XU Yuanyuan, HUANG Xiaoqing, ZHANG Wen, CAO Yang, XIE Jing, ZHOU Huan, HUANG Shunwang.
Study on bioequivalence evaluation of dexamethasone acetate tablets in Chinese healthy volunteers
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(12): 1365-1371.
|
[12] |
LIU Lu, SHI Yufei, HE Qingfeng, XU Fengyan, WANG Kun, CAI Weimin, XIANG Xiaoqiang.
Application of population modeling analysis to evaluate the impact of gene polymorphism on drug PK/PD
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1275-1282.
|
[13] |
ZHOU Jiating, ZHANG Xuan, XIE Zilan, LI Zhi.
Interactions and clinical significance of gut microbiota and levothyroxine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(11): 1307-1314.
|
[14] |
LI Xuejing, JIANG Jinping, LI Sining, WAN Linfei, ZHOU Xiangxiang, YANG Lian, LAN Ke.
A bioequivalence study of generic and brand clozapine in schizophrenic patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1121-1130.
|
[15] |
WU Lili, LIANG Zhi, HUANG Siyong, WANG Yan.
Effect of augmented renal clearance (ARC) on the pharmacokinetics, efficacy, and safety of vancomycin in patients with infective endocarditis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(10): 1139-1145.
|